Zhishu Biotechnology
Fengtai
About Zhishu Biotechnology
Zhishu Biotechnology specialized in the investigation and creation of products for treating injuries to the central nervous system. It fundamentally resolves the issue of central nervous system damage healing and has produced a new model for treating traumatic central nervous system injury by triggering endogenous neurogenesis to produce new neurons.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $4.4M
- Funding stage: Seed
- Last round: Seed (Apr 2023)
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/zhishu-biotechnology-161290 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.